HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B J Jean-Claude Selected Research

3-methyl-1,2,3-triazene

3/2001Design of a chimeric 3-methyl-1,2,3-triazene with mixed receptor tyrosine kinase and DNA damaging properties: a novel tumor targeting strategy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B J Jean-Claude Research Topics

Disease

1Glioma (Gliomas)
12/2010
1Carcinoma (Carcinomatosis)
09/2004
1Neoplasms (Cancer)
03/2001
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2001

Drug/Important Bio-Agent (IBA)

2DNA (Deoxyribonucleic Acid)IBA
12/2010 - 03/2001
2ErbB Receptors (EGF Receptor)IBA
09/2004 - 03/2001
2A-Form DNA (A-DNA)IBA
09/2004 - 03/2001
1Epidermal Growth Factor (EGF)IBA
12/2010
1Gefitinib (Iressa)FDA Link
12/2010
1epidermal growth factor receptor VIIIIBA
12/2010
1Alkylating AgentsIBA
09/2004
1SMA-41IBA
03/2001
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2001
1O(6)-Methylguanine-DNA MethyltransferaseIBA
03/2001
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2001
13-methyl-1,2,3-triazeneIBA
03/2001